Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 83%
In fiscal 2025, Encompass Health Corporation reported revenue of $5.94B, up 10.5% year over year. Operating margin was 17.7% and net margin 9.5%, on a free-cash-flow margin of 7.4% with capital expenditure at 12.4% of revenue. Every figure is computed directly from EHC's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $5.94B | 17.7% | 9.5% |
| FY2024 | $5.37B | 16.1% | 8.5% |
| FY2023 | $4.80B | 15.2% | 7.3% |
| FY2022 | $4.35B | 12.4% | 6.2% |
| FY2021 | $4.01B | 13.9% | 10.3% |
How does EHC compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AACG · ABSI · ACCS · ACHC · ACM · ADUS
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.